Search Results

You searched for : Elililly  

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

Very recently, two global giants, NVIDIA and Eli Lilly and Company had announced a first-of-its-kind AI co-innovation lab focused on applying ...
Feb 20

Mounjaro (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

...
May 12

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ...
Nov 17

A Ray of Hope in Alzheimer's Research: Donanemab Shows Promise in Slowing Cognitive Decline

The findings not only represent a major breakthrough for Eli Lilly but also for the scientific community as a whole, proving that perseverance and dedication ...
Jul 18

Lilly Announces Acquisition of Protomer Technologies

Pharma merger and acquisitions...
Jul 15

Eli Lilly and MiNA Therapeutics Announce saRNA Research Collaboration

MiNA will utilize its saRNA platform to research up to five targets selected by Lilly that aim to address diseases across Lilly's key therapeutic ...
May 15

US government stops distribution of Eli Lilly Covid-19 antibody treatment for Covid-19

The move comes after the detection of different Covid variants ...
Mar 26

Eli Lilly announces agreement to acquire Prevail Therapeutics

The acquisition will establish a new modality for drug discovery and development at Lilly ...
Dec 15

AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19

Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020...
Nov 23

Eli Lilly collaborates with Precision BioSciences for genome editing research

This collaboration will help to accelerate the work aimed to solve genetic diseases with unique editing challenges...
Nov 21

Eli Lilly's bamlanivimab receives US FDA clearance for the treatment of COVID-19

Eli Lilly’s neutralizing antibody bamlanivimab receives US FDA emergency use authorization for the treatment of recently diagnosed COVID-19...
Nov 12

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD....
Nov 06

Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric cancer

Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ...
Oct 28

Eli Lilly announces agreement to acquire Disarm Therapeutics

Eli Lilly successfully develop and commercialize new medicines resulting from the acquisition...
Oct 16

J & J and Eli Lilly halts Covid-19 drug trial

ELI Lilly, J & J and AstraZeneca halts covid drug trials...
Oct 15

Innovent and Eli Lilly announce the NMPA granted marketing approval for HALPRYZA in China

The survival rate is also relatively higher than other tumour types when having appropriate treatment...
Oct 09

Verzinio from Eli Lilly cuts recurrence from Breast Cancer by 25%

Drug combo cuts recurrence risk of breast cancer by 25%...
Sep 21

Anti-inflammatory drug like Baricitinib may shorten Covid-19 recovery time ; Eli Lilly

Eli Lilly said it planned to discuss with regulators the possible emergency use of baricitinib for hospitalized Covid-19 patients. ...
Sep 15

Lilly initiates phase 3 trial of LY-CoV555 for prevention of COVID-19

More than 40 percent of coronavirus deaths in the U.S. linked to long-term care facilities;...
Aug 03

ELI LILLY begins 3rd phase clinical trial with Baricitinib for COVID patients

ELI Lilly close to coronavirus antiviral as 3rd phase trial begins...
Jun 17

ELI Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment

This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly and AbCellera ...
Jun 06

AbCellera and Eli Lilly Agreed to Co-develop Antibody Products to Fight COVID-19

AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create ...
Mar 13

Eli Lilly Announced the Successful Completion of its Acquisition of Dermira, Inc.

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. With this ...
Feb 22

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Post-hoc analysis of the EMPA-REG OUTCOME® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ...
Sep 20

24 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026